Improving immune reconstitution with growth hormone [somatropin] in HIV-infected subjects with incomplete CD4+ lymphocyte restoration on highly active antiretroviral therapy (HAART)
Phase of Trial: Phase II
Latest Information Update: 17 May 2012
At a glance
- Drugs Antiretrovirals; Somatrogon
- Indications HIV infections
- Focus Pharmacodynamics
- 03 May 2012 Actual end date Mar 2005 added as reported by ClinicalTrials.gov.
- 05 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Apr 2010 Results have been published in AIDS Research and Human Retroviruses.